FdaApplication
NDA 022231
Identifiers
- fda_app_no: NDA022231
Properties
| Property | Value |
|---|---|
| applicant_name | MALLINCKRODT PHARMACEUTICALS IRELAND LTD |
| application_type | NDA |
| approval_date | 2022-09-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TERLIVAZ | TERLIPRESSIN ACETATE | EQ 0.85MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product